Nu Skin Enterprises (NUS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Nu Skin Enterprises (NYSE:NUS) announced its quarterly earnings data on Wednesday. The company reported $0.94 earnings per share for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.02), Briefing.com reports. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The business had revenue of $675.31 million for the quarter, compared to the consensus estimate of $664.99 million. During the same period in the prior year, the company earned $0.76 EPS. Nu Skin Enterprises’s quarterly revenue was up 19.8% on a year-over-year basis. Nu Skin Enterprises updated its Q4 guidance to $1.04-1.11 EPS.

Nu Skin Enterprises stock traded down $9.98 during midday trading on Thursday, reaching $62.84. 986,400 shares of the stock traded hands, compared to its average volume of 463,262. The company has a quick ratio of 1.19, a current ratio of 1.82 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $4.04 billion, a price-to-earnings ratio of 19.46, a PEG ratio of 1.78 and a beta of 1.04. Nu Skin Enterprises has a fifty-two week low of $60.82 and a fifty-two week high of $88.68.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Friday, November 30th will be paid a dividend of $0.365 per share. This represents a $1.46 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date is Thursday, November 29th. Nu Skin Enterprises’s payout ratio is 45.20%.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $82.18, for a total transaction of $205,450.00. Following the completion of the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at approximately $2,783,518.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 8,750 shares of company stock valued at $712,100 over the last three months. 5.20% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of the business. Eagle Boston Investment Management Inc. boosted its stake in Nu Skin Enterprises by 2.1% during the 3rd quarter. Eagle Boston Investment Management Inc. now owns 132,063 shares of the company’s stock valued at $10,884,000 after purchasing an additional 2,695 shares during the period. Catalyst Capital Advisors LLC acquired a new position in Nu Skin Enterprises during the 3rd quarter valued at about $717,000. Swiss National Bank boosted its stake in Nu Skin Enterprises by 5.6% during the 3rd quarter. Swiss National Bank now owns 92,200 shares of the company’s stock valued at $7,599,000 after purchasing an additional 4,900 shares during the period. Commonwealth Bank of Australia acquired a new position in Nu Skin Enterprises during the 3rd quarter valued at about $420,000. Finally, MML Investors Services LLC boosted its stake in Nu Skin Enterprises by 48.3% during the 3rd quarter. MML Investors Services LLC now owns 3,974 shares of the company’s stock valued at $328,000 after purchasing an additional 1,295 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages recently weighed in on NUS. Citigroup set a $88.00 price objective on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research report on Thursday. Jefferies Financial Group set a $92.00 price objective on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research report on Thursday. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 23rd. DA Davidson began coverage on shares of Nu Skin Enterprises in a research report on Tuesday, October 9th. They set a “buy” rating and a $92.00 price objective for the company. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their price objective for the company from $57.00 to $70.00 in a research report on Thursday, August 2nd. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. Nu Skin Enterprises currently has an average rating of “Buy” and an average price target of $86.29.

COPYRIGHT VIOLATION WARNING: This news story was posted by WKRB News and is the property of of WKRB News. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.wkrb13.com/2018/11/08/nu-skin-enterprises-nus-releases-earnings-results-misses-expectations-by-0-02-eps.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Read More: What is a Reverse Stock Split?

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply